Denzimol

Overview

Denzimol is an orally active anticonvulsant agent. Denzimol inhibits cytochrome P450 , and interacts with benzodiazepine receptors . Denzimol selectively antagonizes tonic components of Metrazol-induced seizures in rats and mice. Denzimol can be used for the research of epilepsy and convulsions.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Epilepsy | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > GABA Receptor | Products > Signaling Pathways > Sodium Channel | Products > Signaling Pathways > Cytochrome P450

Product Information

• Catalog No.: HY-105059
• CAS No.: 73931-96-1
• Molecular Formula: C19H20N2O
• Molecular Weight: 292.37
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source